CRVS stock · MU stock

CRVS vs MU · $1.04B cap vs P/E 21, rev $37.38B

Corvus Pharmaceuticals Inc (CRVS) versus Micron Technology Inc (MU) — a side-by-side from cached financials, not a winner call.

Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.

Micron Technology Inc (MU) is a semiconductors company listed on US. It is led by Sanjay Mehrotra.

CRVS does not have a complete income-statement cache yet.

Latest reported MU revenue for 2025-08-28 was $37.38B. Net income was $8.54B. MU currently screens at market cap $187.25B and trailing P/E 20.7.

CRVS currently screens at market cap $1.04B. MU currently screens at market cap $187.25B and trailing P/E 20.7.

Not investment advice. Open the CRVS and MU stock pages for the full models.

Not investment advice.

Popular Stock Comparisons